Question: Can FDA authorized resources be used for other facilities?

Answer passage (source: CDC):
page_title: Frequently Asked Questions about Laboratory Testing and COVID-19
section_headers: For All Laboratories: Test Developers
What is NIH's BEI Resources Repository?
section_content: BEI Resources Repositoryexternal
icon was established by the National
Institute of Allergy and Infectious Diseasesexternal
icon at the National Institutes of Health to
provide reagents, tools, and information for studying Category A, B, and
Cexternal icon priority pathogens, emerging infectious diseaseexternal
icon agents, non-pathogenic microbes, and other microbiological
materials of relevance to the research community including diagnostic
developers. Centralizing these functions within BEI Resources facilitates
access to these materials by the scientific community and ensures quality
control of the reagents.

Reviewer feedback on this answer:
No mention of FDA authorization and only addresses BEI Resources Repository, although maybe the link may hold the answer that is needed.
This does not discuss or answer the question directly in regards to FDA resources.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: Frequently Asked Questions about Laboratory Testing and COVID-19
section_headers: For All Laboratories: Accessing Laboratory Testing
Can laboratories use specimen collection devices other than those listed in the manufacturer’s instructions or EUA (e.g., swabs) for SARS-CoV-2 testing?
section_content: According to FDA, when one entity establishes equivalent performance between
parallel testing of the same specimens with the new and original components
(including viral transport media [VTM]), and FDA’s review of the validation
data indicates that it could be applicable to modifications of other tests
with an authorized EUA, FDA will post this information on its website so that
other laboratories can refer to the validation for their testing. Then, other
laboratories do not need to conduct their own bridging study for the same
modification. For additional information regarding FDA’s policy for
modification, see FDA’s frequently asked questionsexternal
icon website.

Reviewer feedback on this answer:
Answer addresses FDA authorization as well using different laboratories and any and all modifications that would have to be done with testing.
This does not answer the question if FDA resources can be used at other facilities.

Reviewer ratings:
Excellent
Bad

Answer passage (source: CDC):
page_title: Frequently Asked Questions about Laboratory Testing and COVID-19
section_headers: For All Laboratories: Accessing Laboratory Testing
When FDA authorizes emergency use for a SARS-CoV-2 point-of-care test, can that test be used in CLIA certificate-of-waiver facilities?
section_content: When the FDA grants an EUA for a point-of-care test, that test is deemed to be
CLIA-waived. For the duration of the national emergency declaration for
COVID-19, such tests can be performed in any CLIA-certified patient care
setting with a certificate of waiver.

Reviewer feedback on this answer:
Answer only addresses point-of-care testing and not all of the "resources" that the requester is talking about. Perhaps a less specific page and one that is more broad with links could help the requester narrow down their needs given the broadness of the scope of the question.
This answer, while answering the question, is not very direct and otherwise convoluted.

Reviewer ratings:
Could be Improved
Acceptable